Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

IASLC MULTIDISCIPLINARY RECOMMENDATIONS FOR PATHOLOGIC ASSESSMENT OF LUNG CANCER RESECTION SPECIMENS FOLLOWING NEOADJUVANT THERAPY.

Travis WD, Dacic S, Wistuba I, Sholl L, Adusumilli P, Bubendorf L, Bunn P, Cascone T, Chaft J, Chen G, Chou TY, Cooper W, Erasmus JJ, Ferreira CG, Goo JM, Heymach J, Hirsch FR, Horinouchi H, Kerr K, Kris M, Jain D, Kim YT, Lopez-Rios F, Lu S, Mitsudomi T, Moreira A, Motoi N, Nicholson AG, Oliveira R, Papotti M, Pastorino U, Paz-Ares L, Pelosi G, Poleri C, Provencio M, Roden AC, Scagliotti G, Swisher SG, Thunnissen E, Tsao MS, Vansteenkiste J, Weder W, Yatabe Y.

J Thorac Oncol. 2020 Jan 28. pii: S1556-0864(20)30026-5. doi: 10.1016/j.jtho.2020.01.005. [Epub ahead of print] Review.

PMID:
32004713
2.

Pulmonary Pathology Society Perspective on the 2018 American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society (ATS/ERS/JRS/ALAT) Idiopathic Pulmonary Fibrosis Clinical Practice Guidelines.

Hariri LP, Smith ML, Mino-Kenudson M, Allen TC, Attanoos R, Borczuk A, Burke L, Cagle PT, Capelozzi V, Dacic S, Guinee D, Raparia K, Roden AC, Roy-Chowdhuri S, Sholl LM, Beasley MB, Churg A.

Ann Am Thorac Soc. 2020 Jan 16. doi: 10.1513/AnnalsATS.201910-801PS. [Epub ahead of print] No abstract available.

PMID:
31945306
3.

Ki-67 Labeling Index in Pulmonary Carcinoid Tumors: Comparison Between Small Biopsy and Resection Using Tumor Tracing and Hot Spot Methods.

Boland JM, Kroneman TN, Jenkins SM, Terra SBSP, Xie H, Molina J, Mounajjed T, Roden AC.

Arch Pathol Lab Med. 2020 Jan 16. doi: 10.5858/arpa.2019-0374-OA. [Epub ahead of print]

PMID:
31944862
4.

PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee.

Lantuejoul S, Sound-Tsao M, Cooper WA, Girard N, Hirsch FR, Roden AC, Lopez-Rios F, Jain D, Chou TY, Motoi N, Kerr KM, Yatabe Y, Brambilla E, Longshore J, Papotti M, Sholl LM, Thunnissen E, Rekhtman N, Borczuk A, Bubendorf L, Minami Y, Beasley MB, Botling J, Chen G, Chung JH, Dacic S, Hwang D, Lin D, Moreira A, Nicholson AG, Noguchi M, Pelosi G, Poleri C, Travis W, Yoshida A, Daigneault JB, Wistuba II, Mino-Kenudson M.

J Thorac Oncol. 2019 Dec 20. pii: S1556-0864(19)33847-X. doi: 10.1016/j.jtho.2019.12.107. [Epub ahead of print] Review.

PMID:
31870882
5.

Distribution of Mediastinal Lesions Across Multi-Institutional, International, Radiology Databases.

Roden AC, Fang W, Shen Y, Carter BW, White DB, Jenkins SM, Spears GM, Molina JR, Klang E, Segni MD, Ackman JB, Sanchez EZ, Girard N, Shumeri E, Revel MP, Chassagnon G, Rubinowitz A, Dicks D, Detterbeck F, Ko JP, Falkson CB, Sigurdson S, Segreto S, Vecchio SD, Palmieri G, Ottaviano M, Marino M, Korst R, Marom EM.

J Thorac Oncol. 2019 Dec 20. pii: S1556-0864(19)33848-1. doi: 10.1016/j.jtho.2019.12.108. [Epub ahead of print]

PMID:
31870881
6.

Ultrastructural changes in pulmonary allografts with antibody-mediated rejection.

Alexander MP, Bentall A, Aleff PCA, Gandhi MJ, Scott JP, Roden AC.

J Heart Lung Transplant. 2020 Feb;39(2):165-175. doi: 10.1016/j.healun.2019.11.022. Epub 2019 Dec 6.

PMID:
31870771
7.

A Recurrence Predictive Model for Thymic Tumors and Its Implication for Postoperative Management: a Chinese Alliance for Research in Thymomas Database Study.

Liu H, Gu Z, Qiu B, Detterbeck FC, Roden AC, Ruffini E, Okumura M, Girard N, Xiang Y, Liu Y, Du Z, Hao Y, Fu J, Zhang P, Pang L, Chen K, Wang Y, Yu Z, Mao T, Fang W; AME Thoracic Surgery Cooperative Group.

J Thorac Oncol. 2020 Mar;15(3):448-456. doi: 10.1016/j.jtho.2019.10.018. Epub 2019 Nov 11.

PMID:
31726106
8.

Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis.

Haak AJ, Kostallari E, Sicard D, Ligresti G, Choi KM, Caporarello N, Jones DL, Tan Q, Meridew J, Diaz Espinosa AM, Aravamudhan A, Maiers JL, Britt RD Jr, Roden AC, Pabelick CM, Prakash YS, Nouraie SM, Li X, Zhang Y, Kass DJ, Lagares D, Tager AM, Varelas X, Shah VH, Tschumperlin DJ.

Sci Transl Med. 2019 Oct 30;11(516). pii: eaau6296. doi: 10.1126/scitranslmed.aau6296.

PMID:
31666402
9.

Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel.

Marchevsky AM, Khoor A, Walts AE, Nicholson AG, Zhang YZ, Roggli V, Carney J, Roden AC, Tazelaar HD, Larsen BT, LeStang N, Chirieac LR, Klebe S, Tsao MS, De Perrot M, Pierre A, Hwang DM, Hung YP, Mino-Kenudson M, Travis W, Sauter J, Beasley MB, Galateau-Sallé F.

Mod Pathol. 2020 Feb;33(2):281-296. doi: 10.1038/s41379-019-0352-3. Epub 2019 Sep 4.

PMID:
31485011
10.

Cryobiopsy in the diagnosis of idiopathic pulmonary hemosiderosis: a case report.

Kania A, Misiaszek M, Vašáková M, Szlubowski A, Bugalho A, Pankowski J, Szołkowska M, Roden AC, Celejewska-Wójcik N, Nastałek P, Gnass M, Sładek K.

J Thorac Dis. 2019 Jul;11(7):3195-3201. doi: 10.21037/jtd.2019.07.17. Review. No abstract available.

11.

Expression of delta-like protein 3 is reproducibly present in a subset of small cell lung carcinomas and pulmonary carcinoid tumors.

Xie H, Boland JM, Maleszewski JJ, Aubry MC, Yi ES, Jenkins SM, Koepplin JW, Terra SBSP, Mansfield AS, Roden AC.

Lung Cancer. 2019 Sep;135:73-79. doi: 10.1016/j.lungcan.2019.07.016. Epub 2019 Jul 17.

PMID:
31447005
12.

Malignant mesothelioma in situ: morphologic features and clinical outcome.

Churg A, Galateau-Salle F, Roden AC, Attanoos R, von der Thusen JH, Tsao MS, Chang N, De Perrot M, Dacic S.

Mod Pathol. 2020 Feb;33(2):297-302. doi: 10.1038/s41379-019-0347-0. Epub 2019 Aug 2.

PMID:
31375770
13.

Clinicopathological, immunophenotypic and genetic studies of mediastinal paragangliomas†.

Hsu YR, Torres-Mora J, Kipp BR, Sukov WR, Jenkins SM, Voss JS, Barr Fritcher EG, Schaff HV, Cassivi SD, Roden AC.

Eur J Cardiothorac Surg. 2019 Nov 1;56(5):867-875. doi: 10.1093/ejcts/ezz115.

PMID:
31329844
14.

Interobserver variation in the assessment of the sarcomatoid and transitional components in biphasic mesotheliomas.

Dacic S, Le Stang N, Husain A, Weynand B, Beasley MB, Butnor K, Chapel D, Gibbs A, Klebe S, Lantuejoul S, Roden AC, Roggli V, Tazelaar H, Vignaud JM, Galateau-Sallé F.

Mod Pathol. 2020 Feb;33(2):255-262. doi: 10.1038/s41379-019-0320-y. Epub 2019 Jul 4.

PMID:
31273316
15.

Pathologic Considerations and Standardization in Mesothelioma Clinical Trials.

Tsao MS, Carbone M, Galateau-Salle F, Moreira AL, Nicholson AG, Roden AC, Adjei AA, Aubry MC, Fennell DA, Gomez D, Harpole D, Hesdorffer M, Hirsch FR, Liu G, Malik S, Nowak A, Peikert T, Salgia R, Szlosarek P, Taioli E, Yang H, Tsao A, Mansfield AS.

J Thorac Oncol. 2019 Oct;14(10):1704-1717. doi: 10.1016/j.jtho.2019.06.020. Epub 2019 Jun 28.

PMID:
31260832
16.

Reanalysis of the NCCN PD-L1 companion diagnostic assay study for lung cancer in the context of PD-L1 expression findings in triple-negative breast cancer.

Rimm DL, Han G, Taube JM, Yi ES, Bridge JA, Flieder DB, Homer R, Roden AC, Hirsch FR, Wistuba II, Pusztai L.

Breast Cancer Res. 2019 Jun 13;21(1):72. doi: 10.1186/s13058-019-1156-6.

17.

Clinical and Histopathologic Features of Immune Checkpoint Inhibitor-related Pneumonitis.

Larsen BT, Chae JM, Dixit AS, Hartman TE, Peikert T, Roden AC.

Am J Surg Pathol. 2019 Oct;43(10):1331-1340. doi: 10.1097/PAS.0000000000001298.

PMID:
31162288
18.

Micropapillary adenocarcinoma of lung: Morphological criteria and diagnostic reproducibility among pulmonary pathologists.

Monroig-Bosque PDC, Morales-Rosado JA, Roden AC, Churg A, Barrios R, Cagle P, Ge Y, Allen TC, Smith ML, Larsen BT, Sholl LM, Beasley MB, Borczuk A, Raparia K, Ayala A, Tazelaar HD, Miller R, Kalhor N, Moran CA, Ro JY.

Ann Diagn Pathol. 2019 Aug;41:43-50. doi: 10.1016/j.anndiagpath.2019.04.008. Epub 2019 Apr 24.

PMID:
31132651
19.

CBX5/G9a/H3K9me-mediated gene repression is essential to fibroblast activation during lung fibrosis.

Ligresti G, Caporarello N, Meridew JA, Jones DL, Tan Q, Choi KM, Haak AJ, Aravamudhan A, Roden AC, Prakash YS, Lomberk G, Urrutia RA, Tschumperlin DJ.

JCI Insight. 2019 May 16;5. pii: 127111. doi: 10.1172/jci.insight.127111.

20.

EWSR1 translocation in primary hyalinising clear cell carcinoma of the thymus.

Porubsky S, Rudolph B, Rückert JC, Küffer S, Ströbel P, Roden AC, Jain D, Tousseyn T, Van Veer H, Huang J, Antonicelli A, Kuo TT, Rosai J, Marx A; International Thymic Malignancy Interest Group (ITMIG).

Histopathology. 2019 Sep;75(3):431-436. doi: 10.1111/his.13890. Epub 2019 Jul 19.

PMID:
31050844
21.

Association between the novel classification of lung adenocarcinoma subtypes and EGFR/KRAS mutation status: A systematic literature review and pooled-data analysis.

Jiang L, Mino-Kenudson M, Roden AC, Rosell R, Molina MÁ, Flores RM, Pilz LR, Brunelli A, Venuta F, He J; AME Lung Cancer Collaborative Group.

Eur J Surg Oncol. 2019 May;45(5):870-876. doi: 10.1016/j.ejso.2019.02.006. Epub 2019 Feb 16.

PMID:
30833014
22.

Efficacy of chest computed tomography prediction of the pathological TNM stage of thymic epithelial tumours.

White DB, Hora MJ, Jenkins SM, Marks RS, Garces YI, Cassivi SD, Roden AC.

Eur J Cardiothorac Surg. 2019 Feb 11. doi: 10.1093/ejcts/ezz013. [Epub ahead of print]

PMID:
30753469
23.

Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease.

Zhang J, Wang D, Wang L, Wang S, Roden AC, Zhao H, Li X, Prakash YS, Matteson EL, Tschumperlin DJ, Vassallo R.

Am J Physiol Lung Cell Mol Physiol. 2019 Mar 1;316(3):L487-L497. doi: 10.1152/ajplung.00301.2018. Epub 2019 Jan 3.

24.

Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer.

Yatabe Y, Dacic S, Borczuk AC, Warth A, Russell PA, Lantuejoul S, Beasley MB, Thunnissen E, Pelosi G, Rekhtman N, Bubendorf L, Mino-Kenudson M, Yoshida A, Geisinger KR, Noguchi M, Chirieac LR, Bolting J, Chung JH, Chou TY, Chen G, Poleri C, Lopez-Rios F, Papotti M, Sholl LM, Roden AC, Travis WD, Hirsch FR, Kerr KM, Tsao MS, Nicholson AG, Wistuba I, Moreira AL.

J Thorac Oncol. 2019 Mar;14(3):377-407. doi: 10.1016/j.jtho.2018.12.005. Epub 2018 Dec 18.

PMID:
30572031
25.

Multifocal Pulmonary Adenocarcinoma with Ground-Glass/Lepidic Features-Exciting Times as the Mystery Is Unfolding.

Roden AC, Mansfield AS.

J Thorac Oncol. 2018 Nov;13(11):1616-1618. doi: 10.1016/j.jtho.2018.08.006. No abstract available.

26.

Idiopathic CD4 Lymphocytopenia with Fulminant Pneumocystis jirovecii Pneumonia.

Jundt MC, Ayalew AM, Hartman TE, Roden AC, Koo CW.

Am J Respir Crit Care Med. 2019 Apr 15;199(8):e35-e36. doi: 10.1164/rccm.201802-0267IM. No abstract available.

PMID:
30321488
27.

EUS fine-needle pancreatic core biopsy can determine eligibility for tumor-agnostic immunotherapy.

Gleeson FC, Levy MJ, Roden AC, Boardman LA, Sinicrope FA, McWilliams RR, Zhang L.

Endosc Int Open. 2018 Oct;6(10):E1278-E1282. doi: 10.1055/a-0650-4447. Epub 2018 Oct 8.

28.

Heterogeneity of programmed death-ligand 1 expression in thymic epithelial tumours between initial specimen and synchronous or metachronous metastases or recurrences.

Terra SBSP, Mansfield AS, Vrana JA, Roden AC.

Histopathology. 2019 Jan;74(2):364-367. doi: 10.1111/his.13750. Epub 2018 Nov 4. No abstract available.

PMID:
30182429
29.

Molecular and Ultrastructural Features of Diffuse Intrapulmonary Malignant Mesothelioma.

Larsen BT, Smith ML, Roden AC, Sukov WR, Hornychová H, Thirumala S, Colby TV, Tazelaar HD.

Am J Surg Pathol. 2019 Jan;43(1):147-150. doi: 10.1097/PAS.0000000000001143. No abstract available.

PMID:
30138217
30.

Personalized treatment of malignant mesothelioma-dream or reality?

Roden AC.

J Thorac Dis. 2018 Jul;10(Suppl 18):S2153-S2156. doi: 10.21037/jtd.2018.06.67. No abstract available.

31.

TUSC3 accelerates cancer growth and induces epithelial-mesenchymal transition by upregulating claudin-1 in non-small-cell lung cancer cells.

Feng S, Zhai J, Lu D, Lin J, Dong X, Liu X, Wu H, Roden AC, Brandi G, Tavolari S, Bille A, Cai K.

Exp Cell Res. 2018 Dec 15;373(1-2):44-56. doi: 10.1016/j.yexcr.2018.08.012. Epub 2018 Aug 9.

PMID:
30098333
32.

Morphometric Study of Pulmonary Arterial Changes in Pulmonary Langerhans Cell Histiocytosis.

Bois MC, May AM, Vassallo R, Jenkins SM, Yi ES, Roden AC.

Arch Pathol Lab Med. 2018 Aug;142(8):929-937. doi: 10.5858/arpa.2017-0463-OA.

PMID:
30040456
33.

Exciting Advances in the Pathogenesis of Neoplastic and Nonneoplastic Lung Diseases, Their Diagnosis, Prognosis, and Treatment.

Roden AC.

Arch Pathol Lab Med. 2018 Aug;142(8):891-892. doi: 10.5858/arpa.2018-0222-ED. No abstract available.

PMID:
30040454
34.

DARPP-32 and t-DARPP promote non-small cell lung cancer growth through regulation of IKKα-dependent cell migration.

Alam SK, Astone M, Liu P, Hall SR, Coyle AM, Dankert EN, Hoffman DK, Zhang W, Kuang R, Roden AC, Mansfield AS, Hoeppner LH.

Commun Biol. 2018;1:43. doi: 10.1038/s42003-018-0050-6. Epub 2018 May 3.

35.

BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma.

Lee HE, Molina JR, Sukov WR, Roden AC, Yi ES.

Hum Pathol. 2018 Sep;79:168-176. doi: 10.1016/j.humpath.2018.05.001. Epub 2018 May 12.

PMID:
29763720
36.

RNAi screening identifies a mechanosensitive ROCK-JAK2-STAT3 network central to myofibroblast activation.

Oh RS, Haak AJ, Smith KMJ, Ligresti G, Choi KM, Xie T, Wang S, Walters PR, Thompson MA, Freeman MR, Manlove LJ, Chu VM, Feghali-Bostwick C, Roden AC, Schymeinsky J, Pabelick CM, Prakash YS, Vassallo R, Tschumperlin DJ.

J Cell Sci. 2018 May 15;131(10). pii: jcs209932. doi: 10.1242/jcs.209932.

37.

Iatrogenic pulmonary lesions.

Roden AC, Camus P.

Semin Diagn Pathol. 2018 Jul;35(4):260-271. doi: 10.1053/j.semdp.2018.03.002. Epub 2018 Mar 23. Review.

PMID:
29631763
38.

Endoscopic Ultrasound-Guided Fine-Needle Biopsies From Pancreatic Ductal Adenocarcinomas Can Be Used to Quantify PD-L1.

Gleeson FC, Zhang L, Roden AC, Levy MJ.

Clin Gastroenterol Hepatol. 2018 Sep;16(9):1535-1536. doi: 10.1016/j.cgh.2018.01.001. Epub 2018 Jan 3. No abstract available.

PMID:
29306039
39.

Histopathologic Findings in Lungs of Patients Treated With Extracorporeal Membrane Oxygenation.

Lee HE, Yi ES, Rabatin JT, Bohman JK, Roden AC.

Chest. 2018 Apr;153(4):825-833. doi: 10.1016/j.chest.2017.12.007. Epub 2017 Dec 20.

PMID:
29274319
40.

Editorial: pleural recurrence of thymoma-what is the value of intra-thoracic chemo-hyperthermia?

Roden AC, Molina JR.

J Thorac Dis. 2017 Oct;9(10):3583-3586. doi: 10.21037/jtd.2017.09.44. No abstract available.

41.

Temporal and spatial heterogeneity of programmed cell death 1-Ligand 1 expression in malignant mesothelioma.

Terra SBSP, Mansfield AS, Dong H, Peikert T, Roden AC.

Oncoimmunology. 2017 Jul 27;6(11):e1356146. doi: 10.1080/2162402X.2017.1356146. eCollection 2017.

42.

Loss of BAP1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma.

Pillappa R, Maleszewski JJ, Sukov WR, Bedroske PP, Greipp PT, Boland JM, Yi ES, Peikert T, Aubry MC, Roden AC.

Am J Surg Pathol. 2018 Feb;42(2):256-263. doi: 10.1097/PAS.0000000000000976.

PMID:
29076876
43.

Histopathology of fungal diseases of the lung.

Roden AC, Schuetz AN.

Semin Diagn Pathol. 2017 Nov;34(6):530-549. doi: 10.1053/j.semdp.2017.06.002. Epub 2017 Jun 14. Review.

PMID:
28684133
44.

Primary mucoepidermoid carcinoma of the lung with prominent clear cells.

Fink DD, Lomas AM, Roden AC, Shah PC, Zreik RT.

Proc (Bayl Univ Med Cent). 2017 Jul;30(3):322-324.

45.

Survival in Surgical and Nonsurgical Patients With Superior Sulcus Tumors.

Xue Z, Wu F, Pierson KE, Mara KC, Yang P, Roden AC, Packard AT, Blackmon S.

Ann Thorac Surg. 2017 Sep;104(3):988-997. doi: 10.1016/j.athoracsur.2017.03.027. Epub 2017 Jun 23.

PMID:
28648538
46.

SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.

Sauter JL, Graham RP, Larsen BT, Jenkins SM, Roden AC, Boland JM.

Mod Pathol. 2017 Oct;30(10):1422-1432. doi: 10.1038/modpathol.2017.61. Epub 2017 Jun 23.

47.

Rapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.

Jain D, Allen TC, Aisner DL, Beasley MB, Cagle PT, Capelozzi VL, Hariri LP, Lantuejoul S, Miller R, Mino-Kenudson M, Monaco SE, Moreira A, Raparia K, Rekhtman N, Roden AC, Roy-Chowdhuri S, da Cunha Santos G, Thunnissen E, Troncone G, Vivero M.

Arch Pathol Lab Med. 2018 Feb;142(2):253-262. doi: 10.5858/arpa.2017-0114-SA. Epub 2017 Jun 22. Review.

PMID:
28639854
48.

Pulmonary sarcomatoid carcinoma-a new hope.

Boland JM, Mansfield AS, Roden AC.

Ann Oncol. 2017 Jul 1;28(7):1417-1418. doi: 10.1093/annonc/mdx276. No abstract available.

49.

Hypersensitivity Pneumonitis A Perspective From Members of the Pulmonary Pathology Society.

Miller R, Allen TC, Barrios RJ, Beasley MB, Burke L, Cagle PT, Capelozzi VL, Ge Y, Hariri LP, Kerr KM, Khoor A, Larsen BT, Mark EJ, Matsubara O, Mehrad M, Mino-Kenudson M, Raparia K, Roden AC, Russell P, Schneider F, Sholl LM, Smith ML.

Arch Pathol Lab Med. 2018 Jan;142(1):120-126. doi: 10.5858/arpa.2017-0138-SA. Epub 2017 Jun 14. Review.

PMID:
28613913
50.

Towards a Molecular Classification of Pulmonary Sarcomatoid Carcinomas.

Mansfield AS, Roden AC, Boland JM.

J Thorac Oncol. 2017 Jun;12(6):910-912. doi: 10.1016/j.jtho.2017.04.012. No abstract available.

Supplemental Content

Loading ...
Support Center